Market Cap | 44.10M | P/E | 2.19 | EPS this Y | - | Ern Qtrly Grth | - |
Income | -7.7M | Forward P/E | 11.91 | EPS next Y | - | 50D Avg Chg | 3.00% |
Sales | 1.3M | PEG | - | EPS past 5Y | - | 200D Avg Chg | -12.00% |
Dividend | N/A | Price/Book | 1.30 | EPS next 5Y | 17.60% | 52W High Chg | -64.00% |
Recommedations | 3.00 | Quick Ratio | 1.08 | Shares Outstanding | 11.53M | 52W Low Chg | 28.00% |
Insider Own | 3.78% | ROA | -7.96% | Shares Float | 9.91M | Beta | 1.04 |
Inst Own | 28.20% | ROE | -23.90% | Shares Shorted/Prior | 45.91K/47.38K | Price | 4.17 |
Gross Margin | 100.00% | Profit Margin | - | Avg. Volume | 30,735 | Target Price | - |
Oper. Margin | -320.92% | Earnings Date | May 13 | Volume | 18,062 | Change | 1.46% |
TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names. The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.
Cantor Fitzgerald | Neutral | Aug 17, 23 |
Cantor Fitzgerald | Neutral | Jul 13, 22 |
HC Wainwright & Co. | Neutral | Jun 7, 22 |
Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
---|---|---|---|---|---|---|---|---|
Walker Marlan D | Chief Executive Offi.. Chief Executive Officer | Apr 12 | Sell | 3.65 | 1,170 | 4,270 | 12,307 | 04/14/23 |
Walker Marlan D | Chief Executive Offi.. Chief Executive Officer | Apr 12 | Option | 0 | 7,508 | 13,477 | 04/14/23 | |
Donegan Michael C | Prin. Fin. and Acctg.. Prin. Fin. and Acctg. Officer | Apr 12 | Option | 0.00 | 50,000 | 61,853 | 04/14/23 | |
Donegan Michael C | Prin. Fin. and Acctg.. Prin. Fin. and Acctg. Officer | Jan 26 | Sell | 5.08 | 1,697 | 8,621 | 11,853 | 01/30/23 |
Donegan Michael C | Prin. Fin. and Acctg.. Prin. Fin. and Acctg. Officer | Jan 26 | Option | 0 | 5,940 | 13,550 | 01/30/23 | |
Donegan Michael C | Prin. Fin. and Acctg.. Prin. Fin. and Acctg. Officer | Jan 23 | Sell | 5.32 | 1,309 | 6,964 | 7,610 | 01/25/23 |
Donegan Michael C | Prin. Fin. and Acctg.. Prin. Fin. and Acctg. Officer | Jan 23 | Option | 0 | 4,365 | 8,919 | 01/25/23 | |
Rubric Capital Management LP | 10% Owner 10% Owner | Dec 30 | Sell | 1333 | 29,000 | 38,657,000 | 01/03/23 | |
Rubric Capital Management LP | 10% Owner 10% Owner | Dec 09 | Buy | 6.09 | 14,825 | 90,284 | 1,757,191 | 12/12/22 |
Bernick Brian | Co-Chief Executive O.. Co-Chief Executive Officer | Dec 06 | Option | 0 | 3,167 | 5,127 | 12/09/22 | |
Bernick Brian | Co-Chief Executive O.. Co-Chief Executive Officer | Dec 06 | Sell | 5.62 | 1,255 | 7,053 | 3,872 | 12/09/22 |
Walker Marlan D | General Counsel General Counsel | Dec 06 | Option | 0 | 2,554 | 7,733 | 12/09/22 | |
Walker Marlan D | General Counsel General Counsel | Dec 06 | Sell | 4.95 | 1,048 | 5,188 | 6,685 | 12/09/22 |
Glickman Mark A | Co-Chief Executive O.. Co-Chief Executive Officer | Dec 06 | Sell | 4.92 | 440 | 2,165 | 1,294 | 12/09/22 |
Glickman Mark A | Co-Chief Executive O.. Co-Chief Executive Officer | Dec 06 | Option | 0 | 1,734 | 1,734 | 12/09/22 | |
Donegan Michael C | Interim CFO/CAO/VP o.. Interim CFO/CAO/VP of Finance | Dec 06 | Option | 0 | 3,476 | 5,464 | 12/09/22 | |
Donegan Michael C | Interim CFO/CAO/VP o.. Interim CFO/CAO/VP of Finance | Dec 06 | Sell | 4.78 | 910 | 4,350 | 4,554 | 12/09/22 |
Rubric Capital Management LP | 10% Owner 10% Owner | Dec 07 | Buy | 5.75 | 20,413 | 117,375 | 1,742,366 | 12/09/22 |
Naughton Gail K | Director Director | Dec 07 | Sell | 5.2614 | 3,922 | 20,635 | 12/08/22 | |
Rubric Capital Management LP | 10% Owner 10% Owner | Oct 28 | Buy | 1000 | 7,000 | 7,000,000 | 29,000 | 10/31/22 |
Rubric Capital Management LP | 10% Owner 10% Owner | Jul 29 | Buy | 413.47 | 580,000 | 239,812,600 | 15,000 | 08/01/22 |
Rubric Capital Management LP | 10% Owner 10% Owner | Jul 15 | Buy | 5.8 | 82,580 | 478,964 | 1,156,953 | 07/19/22 |
Donegan Michael C | CAO and VP of Financ.. CAO and VP of Finance | Nov 30 | Sell | 0.54 | 29,790 | 16,087 | 99,368 | 12/02/21 |
Collins Cooper C. | Director Director | Aug 19 | Buy | 0.75 | 1,000,000 | 750,000 | 1,236,864 | 08/19/21 |
DArecca James | Chief Financial Offi.. Chief Financial Officer | Aug 12 | Sell | 0.87 | 93,337 | 81,203 | 123,830 | 08/12/21 |
Donegan Michael C | CAO and VP Finance CAO and VP Finance | May 12 | Sell | 1.04 | 4,842 | 5,036 | 14,158 | 05/12/21 |
Milligan John C.K. IV | Secretary/CEO of sub.. Secretary/CEO of subsidiary | May 12 | Sell | 1.04 | 44,252 | 46,022 | 1,752,703 | 05/12/21 |
Finizio Robert G | CEO CEO | May 12 | Sell | 1.04 | 67,697 | 70,405 | 17,991,637 | 05/12/21 |